AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial

Reported by Yahoo Finance · Published 19 Aug 2026, 4:10 AM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

7 things you should always keep in your car 11 min ago Dollar falls to three-month low as Treasury moves to soothe bond jitters 33 min ago Epstein-linked port chairman appointed for expertise, says parent firm 42 min ago China ‘firmly opposes’ Trump’s drone tariffs 48 min ago US national debt exceeds US$40 trillion for first time 1 hr ago Australia passes law to levy tech giants that fail to pay for local news 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial

Summary

More in Markets

7 things you should always keep in your car

China is defying the global bond yield surge, boosting its diversification appeal

Retirees: This investment gives you a guaranteed 5% safe withdrawal rate

Jim Cramer drops stunning take on the economy

The chip-stock rally hits a speed bump — but these analysts see reason to be hopeful

ServiceNow’s stock leads a software rally. Here’s what’s energizing investors.